new glp 1 medications Retatrutide for weight loss: Study shows 30% body weight loss What to know about the
Description
Diarrhea can occur instead of or alternating with constipation
The upcoming SURMOUNT-MAINTAIN trial, expected to report results around mid-2026, will specifically compare the 5 mg maintenance dose against higher doses for weight maintenance after initial loss
That creates a dangerous mismatch
GLP-1RA, glucagon-like peptide-1 receptor agonist
MyFitnessPal helps users manage a food diary
Biochim Biophys Acta Bioenerg
